Samalizumab
Product Specifications
CAS Number
1073059-33-2
Target
Immunology/Inflammation related
Related Pathways
Immunology/Inflammation
Purity
0.9564
Bioactivity
Samalizumab (ALXN 6000) is a humanized anti-CD200 monoclonal antibody that specifically targets the CD200 immunoregulatory cell surface protein, a member of the immunoglobulin superfamily which functions to dampen excessive immune responses and maintain self-tolerance, thereby establishing Samalizumab as an effective immune checkpoint inhibitor currently under investigation for the treatment of myeloma and B-cell chronic lymphocytic leukemia (CLL) .
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/121304362390650919/T78295
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
235718 1 Pack (1 Panel (s) x 1 Pack)
W/W008/NL320/TW-210X297-1 Safety & Regulatory Compliance Signs & Labels (Adhesive)
Ask
View Details 
